Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Sewage Testing Helps Track Illicit Drug Use

By HospiMedica staff writers
Posted on 12 Sep 2007
A screening test provides evidence of illicit drug abuse in drug residues and metabolites excreted in urine and flushed toward municipal sewage treatment plants.

Past estimates of illicit drug abuse in a community were based largely on surveys in which children and adults were asked about their use of illegal drugs. More...
Investigators knew that some participants in surveys were not giving honest replies, with individuals being reluctant to admit breaking the law.

The sewage screening approach could provide a fast, reliable, and inexpensive way to track trends in drug use at the local, regional, or state levels while preserving the anonymity of individuals, according to scientist Jennifer Field, Ph.D., an environmental chemist at Oregon State University (Corvallis, OR, USA), who works with colleagues at Oregon State University and at the University of Washington (Seattle, WA, USA).

Dr. Field reported that the screening method under development in her lab improves upon the utility of the laboratory tools currently used to identify traces and metabolites of drugs in such studies. Her lab is refining the technique to verify its accuracy for extremely low concentrations, the order of a few ng/l. Calculations of drug use based solely on byproducts found in water supplies, especially at low levels, can be subject to error, Dr. Field said. To address this issue, her lab is working to identify common indicators, or biomarkers, such as caffeine or nicotine that can be used to sharpen their calculations.

"A lot of things contribute to the flow in wastewater, including agricultural and industrial processes. By linking our illicit drug measurements to biomarkers related to measurable human activities, we could compensate for differences in flows that aren't related to human excretion,” said Dr. Field.

The screening test was described at the 234th national meeting of the American Chemical Society, which took place in Boston (MA, USA) in August 2007.


Related Links:
Oregon State University
University of Washington

Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical Adhesive
MED 5570U
Medical Examination & Procedure Light
Vega 80
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.